Viewing Study NCT00151203


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2025-12-25 @ 5:01 PM
Study NCT ID: NCT00151203
Status: COMPLETED
Last Update Posted: 2021-05-27
First Post: 2005-09-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
Sponsor: Weill Medical College of Cornell University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module